Latest Breaking News On - Calithera biosciences - Page 1 : vimarsana.com

Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of NASDAQ:CALA opened at $0.02 on Friday. Calithera Biosciences has a 12-month low of $0.02 and a 12-month high of $0.50. […]

South san franciscoUnited statesCalithera biosciencesCalithera biosciences company profileCalithera biosciences incFree reportGet free reportCalithera biosciences daily

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiSouth koreaJin wangGenentechf hoffmannAsher biotherapeuticsDaiichi sankyoChipscreen biosciencesBristol myers squibbAshfield medcommsMerck biopharmMerck seronoSamsung bioepisLyell immunopharmaCalithera biosciencesEli lilly

Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of NASDAQ:CALA opened at $0.02 on Friday. The firm has a 50 day moving average of $0.02 and a 200 […]

South san franciscoUnited statesCalithera biosciencesCalithera biosciences incFree reportGet free reportCalithera biosciences daily

Analysts New Coverage for May 24th (AEZS, AIRG, AWX, AZUL, BCLI, BLPH, BWMN, BZ, CALA, CAMP)

Analysts New Coverage for May 24th (AEZS, AIRG, AWX, AZUL, BCLI, BLPH, BWMN, BZ, CALA, CAMP)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesSanfordc bernsteinRedburn atlanticInnsuites hospitality trustCitigroup incNews ratings for aeterna zentaris inc dailyMarin softwareJaguar healthCb financial servicesInternational tower hill minesBowman consulting groupLiqtech internationalCredit suisse groupMorgan stanleyRubicon technologyAeterna zentaris inc

Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Calithera Biosciences stock opened at $0.02 on Thursday. The stock has a 50-day moving average of $0.02 and a two-hundred […]

South san franciscoUnited statesCalithera biosciencesCalithera biosciences incFree reportGet free reportCalithera biosciences daily